Skin Disease and Microbiome: Last Chance to Join
Preview text: Join Dr George Moncreiff for practical insight from a primary care dermatology…
Use this example
- Subject
- Skin Disease and Microbiome: Last Chance to Join
- Preview text
- Join Dr George Moncreiff for practical insight from a primary care dermatology…
- From
- hcp@
symproveforprofessionals.com - ESP
- Klaviyo
- Sent
- Wed Sep 16, 2026, 9:04 AM ET
- Sent to
- professionals.symprove.com
- Size
- 61 KB
- Images
- 7
- Links
- 9, 5 of them buttons
- Subject length
- 48 characters
Against Symprove Professionals's usual
Sent in the 9 AM hour, which holds 23% of its emails; 36% arrive in the 5 AM hour. The subject is 48 characters; its average is 47.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Symprove Professionals <[email protected]>
- Subject
- Skin Disease and Microbiome: Last Chance to Join
- Date
- Wed, 16 Sep 2026 13:04:46 +0000
- Message-ID domain
- klaviyomail.com
- Return-Path domain
- k3.email.symproveforprofessionals.com
- DKIM signature
- d=shared.klaviyomail.com s=def1; d=email.symproveforprofessionals.com s=mtd1
- List-Unsubscribe
- Present, one-click
Servers it passed through, newest first
- from (unnamed) by kmta-mta-blue-….servers.clovesoftware.com with SMTP
Other sending headers (names only): X-Mailer-Info-Extra2, X-Mailer-Info, X-Mailer-Info-Extra, X-Kmail-Account, X-Kmail-Message, X-Kmail-Ops, X-Report-Abuse
Sent just before and after
| Oct 7, 2026 5:00 AM | Join us: The Role of Probiotics in Constipation | |
| Oct 1, 2026 11:08 AM | Probiotics in Perimenopausal Women: Insights from the Largest Real-World Study | |
| Sep 23, 2026 9:01 AM | A GP perspective on the gut-skin axis | |
| Sep 16, 2026 9:04 AM | Skin Disease and Microbiome: Last Chance to Join (this email) | |
| Sep 9, 2026 9:06 AM | Access New Clinical Masterclasses | |
| Sep 2, 2026 9:07 AM | Join Us To Discuss Microbiome In Skin Disease | |
| Aug 20, 2026 5:01 AM | Explore the evidence for probiotics in GERD, dyspepsia and H. pylori |
More from Symprove Professionals
All Symprove Professionals emailsWhat is Symprove's mechanism of action?
Nov 10, 2026 11:46 PM
What’s new in menopause management for 2026?
Nov 4, 2026 5:00 AM
Oct 30, 2026 2:10 AM
Now available to watch: The role of probiotics in constipation
Oct 28, 2026 6:02 AM
Oct 28, 2026 12:45 AM
NEW study: Symprove in Ehlers-Danlos Syndrome (EDS)
Oct 26, 2026 6:15 AM
The Role of Probiotics in Constipation: Last Chance to Join
Oct 20, 2026 5:00 AM
Welcome to Symprove Professionals
Oct 16, 2026 2:09 AM
